This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Evive Biotechnology (Shanghai) Ltd, Itabmed (Hk) Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Wuzhong Shen: Innovator in Bispecific Antigen Binding Proteins
Introduction
Wuzhong Shen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antigen binding proteins. His innovative work has the potential to impact cancer treatment significantly.
Latest Patents
Wuzhong Shen holds a patent for "Anti-CD19 and anti-CD3 bispecific antigen binding proteins and uses thereof." This invention provides bispecific antigen binding proteins (BSAPs) that specifically bind to CD3 and a tumor antigen, such as CD19. The patent outlines the uses of these BSAPs for preparing pharmaceutical compositions, methods of treating cancer, and kits that include the BSAPs. He has 1 patent to his name.
Career Highlights
Wuzhong Shen is associated with Itabmed (HK) Limited, where he continues to advance his research and development efforts. His work focuses on creating innovative solutions for complex medical challenges, particularly in oncology.
Collaborations
Wuzhong collaborates with notable colleagues, including Zhihua Huang and Yiqun Rao. Their combined expertise enhances the research and development efforts at Itabmed.
Conclusion
Wuzhong Shen's contributions to the field of bispecific antigen binding proteins exemplify the innovative spirit of modern biotechnology. His work holds promise for improving cancer treatment options and showcases the importance of collaboration in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile